BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) kopieguldījumu fonda cena un jaunumi

SākumlapaSHSKX • Ieguldījumu fonds

BlackRock Health Sciences Opportunities Portfolio Class K

71,37 $

6. febr. · USD · MUTF · Atruna

Fidelity Select Health Care Portfolio

27,92 $

FSPHX1,68%

BlackRock Health Sciences Opportunities Portfolio Investor C Shares

50,55 $

SHSCX1,79%

BlackRock Health Sciences Opportunities Portfolio Institutional Shares

71,19 $

SHSSX1,80%

BlackRock Health Sciences Opportunities Portfolio Class R

62,68 $

BHSRX1,80%

BlackRock Health Sciences Opportunities Portfolio Service Shares

65,86 $

SHISX1,81%

Janus Henderson Global Life Sciences Fund Class A

79,57 $

JFNAX1,70%

Janus Henderson Global Life Sciences Fund Class I

81,88 $

JFNIX1,70%

Janus Henderson Global Life Sciences Fund Class C

67,79 $

JFNCX1,70%

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

65,43 $

SHSAX1,79%

Fidelity Emerging Markets Discovery Fund

21,04 $

FEDDX1,06%

Ieguldījumu fonds

Slēgšanas kurss

70,10 $

Peļņa no gada sākuma

0,11%

Izdevumu koeficients

0,75%

Kategorija

Healthcare Sector Equity

Morningstar vērtējums

Neto aktīvi

488,19 milj. USD

Peļņa

0,42%

Komisija

Ieviešanas datums

2016. gada 8. jūn.

Tirgus ziņas

Simply Wall Street

pirms 21 stundas

Subdued Growth No Barrier To United Homes Group, Inc. (NASDAQ:UHG) With Shares Advancing 26%

TradingView

pirms 2 dienām

No Surprises In Power Integrations’s (NASDAQ:POWI) Q4 Sales Numbers But Inventory Levels Increase

POWI

0,30%

The National Law Review

pirms 2 dienām

Satellos Announces Launch of Public Offering in Canada and the Un

No Surprises In Amtech's (NASDAQ:ASYS) Q4 Sales Numbers But Stock Drops 11.2%

Jim Cramer Reveals Why Bitcoin Is No Longer Linked to S&P 500

Weekend Reading | Howard Marks' Latest Fireside Chat: A 30x P/E Ratio Isn't Expensive for Truly Great Companies; What to Worry About Are Those Outside the 'Magnificent Seven' of the S&P 500